Search for Clinical Trial Results

Sponsored By

Blastic Plasmacytoid Dendritic Cell - 11 Studies Found

Status Study
Recruiting Study Name: SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia
Condition:
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • Acute Myel
    Date: 2014-03-13
    Interventions: Drug: SL-401
Recruiting Study Name: Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
Condition:
  • Adult Acute Myeloid Leukemia in Remission
  • Donor
  • Early Rela
    Date: 2014-06-06
    Interventions:
    • Drug: cyclophosphamide Given I
Completed Study Name: Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)
Condition:
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Hematological Mali
    Date: 2016-07-21
Active, not recruiting Study Name: DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Condition:
  • Leukemia
  • Myelodysplastic Syndromes
  • B
    Date: 2006-11-08
    Interventions: Drug: DT388IL3 Intravenously via a 3 cc plastic syringe as a 15 minute bolus infusion daily for five day
Recruiting Study Name: PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
Condition:
  • Acute Myelogenous Leukemia
  • B-cell Acute Lymphoblastic Leukemia
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Hepatosplenic T-Ce
    Date: 2017-03-01
    Interventions:
    • Other: Laboratory Biomarker Analysis

Recruiting Study Name: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Condition:
  • Adult Nasal Type Extranodal NK/T-Cell Lymphoma
  • Adult T-Cell Leukemia/Lymphoma
  • Date: 2016-01-08
    Interventions:
    • Other: Laboratory Biomarker Analysis

Recruiting Study Name: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Biphenotypic Leukemi
    Date: 2014-08-18
    Interventions:
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed Study Name: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Acute Leukemias of Ambiguous Lineage
    • Date: 2010-10-29
    Interventions:
    • Drug: Akt inhibitor MK2206 Giv
Active, not recruiting Study Name: Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Condition:
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • Acute Undifferentiated Leukemia
    Date: 2001-04-10
    Interventions:
    • Drug: fludarabine phosphate Gi
Next >>>